Ledger.Open graph →
SEC Form D · Amendment · filed February 26, 2021

Item 9 Labs Corp

Offering
$13.0M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PHOENIX, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Jeffrey L. Rassas · Phoenix, AZExec · DirectorBryce L. Skalla · Phoenix, AZExec · DirectorRobert Mikkelsen · PHOENIX, AZExecAndrew Bowden · Phoenix, AZExec · DirectorRonald L. Miller, Jr · Phoenix, AZDirectorMichael L. Keskey · Phoenix, AZDirectorChristopher L. Wolven · Phoenix, AZExecDouglas L. Bowden · Phoenix, AZDirectorRobert Mikkelsen · PHOENIX, AZExecAndrew Bowden · Phoenix, AZExec · DirectorRonald L. Miller, Jr · Phoenix, AZDirectorMichael L. Keskey · Phoenix, AZDirectorJeffrey L. Rassas · Phoenix, AZExec · DirectorChristopher L. Wolven · Phoenix, AZExecDouglas L. Bowden · Phoenix, AZDirectorBryce L. Skalla · Phoenix, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗